Dr. Jim Malone, a distinguished professional with roots from Butler University and Indiana University School of Medicine, has devoted his career to making a lasting impact on those with type 1 diabetes. With 12 years private practice experience in Indianapolis as a diabetes specialist, Dr. Malone seamlessly transitioned into a 21-year career at Eli Lilly & Company, contributing significantly to clinical research in diabetes products and insulin delivery device development.
After retiring from Lilly in 2018, Dr. Malone began consulting with several companies in the diabetes field and part-time teaching Endocrinology at the Marian University College of Osteopathic Medicine. In 2020, he joined a biotech start-up in California, Bigfoot Biomedical, as Chief Medical Officer to further develop and commercialize a connected insulin pen system for patients on Multiple Daily Insulin Injections. Bigfoot Biomedical was recently acquired by Abbott Laboratories and Dr. Malone joined Abbott Diabetes Care as Medical Lead – Insulin Delivery Devices to continue the work he began with Bigfoot. Dr. Malone’s passion lies in harnessing innovative opportunities within diabetes technology, foreseeing the transformative impact on individuals living with diabetes.
In addition to his exemplary professional pursuits, Dr. Malone has been a pivotal figure in the leadership of the Breakthrough T1D Indiana and Kentucky chapter. His 12-year service on the Breakthrough T1D Indiana Community Board, including a term as President from July 2020 to July 2021, showcased his adept guidance during the challenging pandemic years. Today, Jim actively supports Breakthrough T1D’s mission as a dedicated cyclist in the Breakthrough T1D Ride to Cure Program. Recognized for his inspirational role, he received his 10-year Breakthrough T1D Ride to Cure participant jersey in September 2023 at the Grand Rapids, MI Ride to Cure. Dr. Malone consistently embodies encouragement and support, making him an invaluable asset to his fellow riders and the diabetes community at large.